35results about How to "Good index" patented technology

A lighting device comprising at least one solid state light emitter and at least one lumiphor. If each solid state light emitter is illuminated and each lumiphor is excited, a mixture of light emitted has x, y color coordinates within an area defined by the coordinates 0.32, 0.40; 0.36, 0,48; 0.43, 0.45; 0.42, 0.42; and 0.36, 0.38. The lumiphor(s) comprises phosphor particles, in the range of from 3 to 7 micrometers (or 5-15, 10-20, or 15-25 micrometers), or having a mean particle size of 5, 10, 15, 20 micrometers. Also, a lighting device comprising at least one emitter and at least one lumiphor in which the lumiphor comprises phosphor particles having sizes as mentioned above, where the lighting device has an efficacy of at least 60 (or 70, or 80) lumens per watt.

A lamp comprising a solid state light emitter, the lamp being an A lamp and providing a wall plug efficiency of at least 90 lumens per watt. Also, a lamp comprising a solid state light emitter and a power supply, the emitter being mounted on a heat dissipation element, the dissipation element being spaced from the power supply. Also, a lamp, comprising a solid state light emitter and a heat dissipation element that has a heat dissipation chamber, whereby an ambient medium can enter the chamber, pass through the chamber, and exit. Also, a lamp, comprising a light emissive housing at least one solid state lighting emitter and a first heat dissipation element. Also, a lamp comprising a heat sink comprising a heat dissipation chamber. Also, a lamp comprising first and second heat dissipation elements. Also, a lamp comprising means for creating flow of ambient fluid.

A sign comprising a surface having a display, and a plurality of sources of visible light. The sources of visible light are oriented to illuminate at least a portion of the display, and include solid state light emitters and/or luminescent materials. Line segments drawn on a Chromaticity Diagram connecting coordinates of some of the illumination color hues define a shape which encompasses coordinates of the display color hue(s). Also, a sign comprising a surface having a display having a surface area of at least 4 square meters, and at least 100 sources of visible light including solid state light emitters and/or luminescent materials. Also, a sign comprising a white light source and at least one additional source of light. Also, methods of illuminating signs.

A lamp comprising a solid state light emitter, the lamp being an A lamp and providing a wall plug efficiency of at least 90 lumens per watt. Also, a lamp comprising a solid state light emitter and a power supply, the emitter being mounted on a heat dissipation element, the dissipation element being spaced from the power supply. Also, a lamp, comprising a solid state light emitter and a heat dissipation element that has a heat dissipation chamber, whereby an ambient medium can enter the chamber, pass through the chamber, and exit. Also, a lamp, comprising a light emissive housing at least one solid state lighting emitter and a first heat dissipation element.

The invention relates to compounds of formula IA

and pharmaceutically acceptable derivatives thereof, compositions comprising an effective amount of a compound of formula IA or a pharmaceutically acceptable derivative thereof, and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a compound of formula IA or a pharmaceutically acceptable derivative thereof.

The invention relates to an ultrasonic reactor based on a diffuse sound field, in particular to a device for treating liquid by utilizing an ultrasonic cavitation effect. The ultrasonic reactor comprises a tank body (1), an ultrasonic transducer (3) and a sound reflector (20), wherein the tank body (1) is used for containing liquid to be treated; the ultrasonic transducer (3) is installed in the tank body; and the sound reflector (20) is positioned on the wall surface of the tank body opposite to the radiating surface (24) of the ultrasonic transducer (3) and is provided with a sound reflecting surface which is not perpendicular to influent sound waves emitted by the ultrasonic transducer (3). The ultrasonic reactor carries out sound treatment to the liquid in the ultrasonic reactor by utilizing a uniform ultrasonic field to realize the uniform sound treatment of the ultrasonic reactor and improve the utilization ratio of sound energy in the ultrasonic reactor.

An ultraviolet-curable pressure-sensitive adhesive composition, comprising one or more monomer components comprising an acrylic monomer; an aromatic low-molecular-weight polymer having a weight-average molecular weight of 500 to 4000 inclusive, the molecular weight being according to gel permeation chromatography; and a photopolymerization initiator; wherein when the composition is turned into a pressure-sensitive adhesive layer, the haze value of the composition is 10% or less.

The structural design, preparative methods and chemical composition of two structural formulations of bivalent vaccines against morphine-heroin addiction (morphine-6-hemisuccinyl-EDC-TFCS-tetanus toxoid and 3-O-carboxymethylmorphine-EDC-TFCS-tetanus toxoid), are disclosed. These vaccines are suitable for human use in which they are capable of triggering the synthesis of polyclonal antibodies against morphine opiate and its structural analogue, heroin, through the repeated in vivo administration of these formulations, in active vaccination protocols, in pre-clinical studies in rodents. The active vaccination paradigm through which these immunogens trigger a humoral immune response consolidated with a long-term immunological memory, characterized by the presence of high titers of specific antibodies against these two drugs of abuse, is also disclosed. Furthermore, the present invention reveals the efficacy of these conjugate formulations for triggering a sustained immunoprotection against morphine and heroin addiction using an intravenous self-administration paradigm of these two opiate substances in the rodent. Finally, a discussion is also made on the potential future use of these immunoconjugates in active vaccination protocols for treating both morphine and heroin addiction in the humans.

The invention relates to a variable cross-section standing wave ultrasonic reactor which relates to a device for processing a liquid by utilizing an ultrasonic cavitation effect. The variable cross-section standing wave ultrasonic reactor comprises a box body, at least one ultrasonic transducer (10) and an ultrasonic transducer driving circuit, wherein the box body is used for containing the processed liquid. The cross-sectional area of a standing wave sound field in the box body periodically changes along with the position of a cross section, and the cross section of the sound field is minimum at the position (a sound pressure nodal surface) where a sound pressure amplitude is zero; the cross section of the sound field is maximum at the position (a sound pressure antinodal surface) where the sound pressure amplitude is maximum; and the cross section of the sound field is linearly or nonlinearly transited from the minimum to the maximum between the adjacent sound pressure nodal and antinodal surfaces. The volume of the liquid near the sound pressure antinodal surface is increased and the volume of the liquid near the sound pressure nodal surface is decreased to improve the utilization ratio of the sound field energy of the ultrasonic reactor.

Disclosed is a family of corroles for its use in the treatment of an infection by human herpesvirus, especially in the treatment of an infection by human cytomegalovirus.

A process for producing a gas oil fraction by hydrodesulfurizing a feedstock oil prepared by blending a straight-run gas oil and a light cycle oil, wherein the process is capable of maintaining the activity of the desulfurization catalyst over a long period, and is capable of producing a low-sulfur gas oil fraction having a low sulfur content and excellent color index. The process for producing a low-sulfur gas oil fraction includes hydrodesulfurizing a feedstock oil to a sulfur content of not more than 10 ppm by mass, wherein the feedstock oil is prepared by blending a straight-run gas oil with a light cycle oil having a 10 volume % distillation temperature of less than 220° C. and a 90 volume % distillation temperature of less than 325° C., such that the blend proportion of the light cycle oil is not more than 30% by volume. Further, a low-sulfur gas oil is obtained by blending the low-sulfur gas oil fraction with a kerosene fraction.

The present invention relates to hydrogenated linear copolymers comprising butadiene and isoprene monomer units, as well as the process for preparing these copolymers. The invention further relates to a lubricating oil composition comprising one or more hydrogenated linear copolymers according to the invention, as well as to the use of the aforementioned copolymers as a lubricant additive or a synthetic base fluid for lubricant compositions, especially in gear oils, transmission oils, hydraulic oils, engine oils, grease, marine oils or industrial lubricating oils.

Provided is an insert that has good positioning precision and sufficient rigidity. Said insert is rod-shaped and has: a shank part; cutting blades formed on both sides of the shank part; and raised surfaces that are positioned between the cutting blades and the shank part and bulge such that parts farther away from the cutting blades are progressively closer to the outer surface of the shank part. In a side view, the rake face of the cutting blade on one side and the raised surface on the other side are disposed in the same direction with respect to the axis of rotation of the shank part.